Abstract
The given topic is wide, and I feel it necessary to Start with some limitations and definitions. In my lecture thrombolytic treatment will be synonymous to Streptokinase treatment. Although other thrombolytic agents or combinations have been widely used, such as Urokinase; plasmin with or without Streptokinase; Streptokinase plasminogen; acylated Streptokinase; Brinase; and most promising tissue plasminogen activator, the scientificly documented research with Streptokinase in clinical mediane with venous thrombosis is dominating.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arnesen H, Heilo A, Jakobsen E, Ly B, Skaga E (1978) A prospecitve study of Streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand 203: 457–463
Arnesen H, Hoiseth A, Ly B (1982) Streptokinase or heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand 211: 65–68
Common HH, Seaman AJ, Rosch J, Porter JM, Dotter CT (1976) Deep vein thrombosis treated with Streptokinase or heparin. Follow–up of a randomized study. Angiology 27: 645–654
Duckert F, Müller G, Nyman D, Benz A, Prisender S, Madar G, Da Silva MA, Widmer LK, Schmitt HE (1975) Treatment of deep vein thrombosis with Streptokinase. Br Med J 1: 479–481
Elliot MS, Immelmann EJ, Jeffery P, Benatar SR (1979) A comparative randomized trial of heparin versus Streptokinase in the treatment of acute proximal venous thrombosis. Br J Surg 66: 838–843
Johannson E, Ericson K, Zetterquist S (1976) Streptokinase treatment of deep venous thrombosis of the lower extremity. Acta Med Scand 199: 89–94
Kakkar W, Flanc C, Howe CT, O’Shea M, Flute PT (1969) Treatment of deep vein thrombosis. A trial of heparin, Streptokinase and Arvin. Br Med J 1: 806–810
Ly B, Arnesen H, Eie H, Hol R (1978) A eontrolled elinieal trial of Streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 203: 465–470
Marder VJ (1979) The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Aim Intern Med 90: 802–808
O’Donnell TF, Browse NL, Burnand KG, Thomas ML (1977) The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 22: 483–488
Straub H (1982) Letale Komplikationen der Fibrinolyse. Münch Med Wschr 124: 17–19
Tsapogas MJ, Peabody RA, Wu KT, Karmody AM, Devaraj KT, Eckert C (1973) Controlled study of thrombolytic therapy in deep vein thrombosis. Surgery 74: 973–984
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin, Heidelberg
About this paper
Cite this paper
Arnesen, H. (1985). Thrombolytic Treatment of Peripheral Venous Occlusion. Critical Analysis of Beneflt and Risk. In: van de Loo, J., Asbeck, F. (eds) Aktueller Stand der Thrombolysetherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70206-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-70206-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15076-3
Online ISBN: 978-3-642-70206-8
eBook Packages: Springer Book Archive